ZyVersa Therapeutics, Inc. - ZVSA
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Walleye Capital LLC | History | New | 980,568 | 128 | 0.0% | — | 1 | +980,568 | New | Q3 2023 | Nov 21, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | History | New | 123,130 | 16 | 0.0% | — | 2 | +123,130 | New | Q3 2023 | Nov 13, 2023 |
| XTX Topco Ltd | History | New | 16,709 | 2 | 0.0% | — | 4 | +16,709 | New | Q3 2023 | Nov 13, 2023 |
| VANGUARD GROUP INC | History | No change | 17,194 | 2 | 0.0% | 0.0% | 3 | 0 | 0.0% | Q3 2023 | Dec 18, 2023 |
| MILLENNIUM MANAGEMENT LLC | History | New | 15,190 | 1 | 0.0% | — | 5 | +15,190 | New | Q3 2023 | Nov 14, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | History | New | 13,537 | 1 | 0.0% | — | 6 | +13,537 | New | Q3 2023 | Nov 14, 2023 |
| BARCLAYS PLC | History | Closed out | 0 | 0 | — | — | — | -1,100 | -100.0% | Q3 2023 | Mar 26, 2026 |
| UBS Group AG | History | New | 107 | 0 | — | — | — | +107 | New | Q3 2023 | Nov 09, 2023 |
| WELLS FARGO & COMPANY/MN | History | Added to | 161 | 0 | — | — | — | +52 | 47.71% | Q3 2023 | Nov 13, 2023 |
| Tower Research Capital LLC (TRC) | History | Added to | 5,766 | 0 | — | 0.0% | — | +20 | 0.35% | Q3 2023 | Nov 14, 2023 |
| BANK OF AMERICA CORP /DE/ | History | No change | 100 | 0 | — | — | — | 0 | 0.0% | Q3 2023 | Nov 14, 2023 |